Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein

Cell Growth and Differentiation

Volumn 8, Issue 12, 1997, Pages 1277-1286

  Berezutskaya, Ekaterena ^a   Yu, Bo ^a   Morozov, Alexei ^a,b   Raychaudhuri, Pradip ^a   Bagchi, Srilata ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEASOME; RETINOBLASTOMA PROTEIN; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; HALF LIFE TIME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WART VIRUS;

ACETYLCYSTEINE; ADENOVIRUS E1A PROTEINS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; TRANSFECTION;

ADENOVIRIDAE; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPOVAVIRIDAE;

EID: 0031442175     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Laimins, L. The biology of human papillomaviruses: from warts to cancer. Infect. Agents Dis., 2: 74-86, 1993.
2. Lowy, D., Kernbauer, R., and Schiller, J. Genital human papillomavirus infection. Proc. Natl. Acad. Sci. USA, 91: 2436-2440, 1994.
3. Vousden, K. Interactions between papillomavirus proteins and tumor suppressor gene products. Adv. Cancer Res., 64: 1-24, 1994.
4. zur Hausen, A., and de Villiers, E. Human papillomaviruses. Annu. Rev. Microbiol., 48: 427-447, 1994.
5. Adler-Storthz, K., Ficarra, G., Woods, K. V., and Gaglioti, D. Prevalence of Epstein-Barr virus and human papillomavirus in oral mucosa of HIV-infected patients. J. Oral. Pathol. Med., 21: 164-170, 1992.
6. Sheffner, M., Wereness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
7. Crook, T., Tidy, J. A., and Vousden, K. H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell, 67: 547-556, 1991.
8. Hecks, D. V., Yee, C. L., Howley, P. M., and Münger, K. Efficiency of binding to the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA, 89: 4442-4446, 1992.
9. Dyson, N., Howley, P. M., Münger, K., and Harlow, E. The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
10. Halbert, C., Demmers, G., and Galloway, D. The E7 gene of human papillomavirus type 16 is sufficient for transformation of human epithelial cells. J. Virol., 65: 473-478, 1991.
11. Hawley-Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., and Schiller, J. T. HPV16 E6 and E7 cooperate to immortalize human foreskin keratinocytes. EMBO J., 8: 3905-3910, 1989.
12. Münger, K., Phelps, W. C., Bubb, V., Howley, P. M., and Schlegel, R. J. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63: 4417-4421, 1989.
13. Watanabe, S., Kanda, T., and Yoshiike, K. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J. Virol., 63: 965-969, 1989.
14. Phelps, W. C., Bagchi, S., Barnes, J. A., Raychaudhuri, P., Kraus, V., Münger, K., Howley, P. M., and Nevins, J. R. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J. Virol., 65: 6922-6930, 1991.
15. Huibregtse, J. M., Scheffner, M., and Howley, P. M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J., 10: 4129-4135, 1991.
16. Maki, C. G., Huibregtse, J. M., and Howley, P. M. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res., 56: 2649-2654, 1996.
17. White, A. E., Livanos, E. M., and Tlsty, T. D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev., 8: 666-677, 1994.
18. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937-948, 1992.
19. Dyson, N., Guida, P., Münger, K., and Harlow, E. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol., 66: 6893-6902, 1992.
20. Arroyo, M., Bagchi, S., and Raychaudhuri, P. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Mol. Cell. Biol., 13: 6537-6546, 1993.
21. Davies, R., Hicks, R., Crook, T., Morris, J., and Vousden, K. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J. Virol., 67: 2521-2528, 1993.
22. McIntyre, M., Ruesch, M., and Laimins, L. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology, 215: 73-82, 1996.
23. Morozov, A., Shiyanov, P., Barr, E., Leiden, J. M., and Raychaudhuri, P. HPV16 E7 bypasses G1 arrest induced by serum starvation and by the expression of p21. J. Virol., 71: 3451-3457, 1997.
24. Cheng, S., Schmidt-Grimminger, D., Murant, T., Broker, T., and Chow, L. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev., 9: 2335-2349, 1995.
25. Demmers, G., Foster, S., Halbert, C., and Galloway, D. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7 protein. Proc. Natl. Acad. Sci. USA, 97: 4382-4386, 1994.
26. Hickman, E., Picksley, S., and Vousden, K. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced by p53 activation. Oncogene, 9: 2177-2181, 1994.
27. Jones, D. L., and Munger, K. Analysis of the p53-mediated growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol., 71: 2905-2912, 1997.
28. Ruesch, M. N., and Laimins, L A. Initiation of DNA synthesis by human papillomavirus E7 oncoprotein is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. J. Virol., 71: 5570-5578, 1997.
29. Nevins, J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (Washington DC), 258: 424-429, 1992.
30. 1-S regulatory genes. Mol. Cell. Biol., 15: 4215-4224, 1995.
31. Slansky, J. E., Li, Y., Kaelin, W. G., Jr., and Farnham, P. J. A protein synthesis dependent increase in E2F1 mRNA correlates with growth regulation of the DHFR promoter. Mol. Cell. Biol., 13: 1610-1618, 1993.
32. Ohtani, K., DeGregori, J., and Nevins, J. R. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA, 92: 12146-12150, 1995.
33. Helin, K., and Harlow, E. The retinoblastoma protein as a transcriptional represser. Trends Cell Biol., 3: 43-46, 1993.
34. Weintraub, S. J., Prater, C. A., and Dean, D. C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature (Lond.), 358: 259-261, 1992.
35. Weintraub, S. J., Chow, K. N. B., Luo, R. X., Zhang, S. H., He, S., and Dean, D. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature (Lond.), 375: 812-815, 1995.
36. Shiyanov, P., Bagchi, S., Adami, G. R., Kokontis, J., Hay, N., Arroyo, M., Morozov, A., and Raychaudhuri, P. p21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol. Cell. Biol., 16: 737-744, 1996.
37. Shiyanov, P., Hayes, S., Chen, N., Pestov, D., Lau. L, and Raychaudhuri, P. p27Kip1 induces an accumulation of the repressor complexes of E2F and inhibits the E2F-regulated genes. Mol. Biol. Cell., 80: 1815-1827, 1997.
38. Chellapan, S., Kraus, V. B., Kroger, B., Münger, K., Howley, P. M., Phelps, W. C., and Nevins, J. R. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA, 89: 4549-4553, 1992.
39. Phelps, W. C., Munger, K., Yee, C. L, Barnes, J. A., and Howley, P. M. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J. Virol., 66: 2418-2427, 1992.
40. Jewers, R. J., Hilderbrandt, P., Ludlow, J. W., Kell, B., and McCance, D. J. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol., 66: 1329-1335, 1992.
41. McIntyre, M., Frattini, M., Grossman, S., and Laimins, L. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J. Virol., 67: 3142-3150, 1993.
42. Boyer, S. N., Wazer, D. E., and Band, V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteosome pathway. Cancer Res., 56: 4620-4624, 1996.
43. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, R. E. Keratinization in a spontaneously immortalized human keratinocyte cell line. J. Cell. Biol., 106: 761-771, 1988.
44. Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., and Weinberg, R. A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell, 73: 1013-1023, 1993.
45. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J. Y., and Livingston, D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73: 487-497, 1993.
46. Ikeda, M., Jakoi, L, and Nevins, J. R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA, 93: 3215-3220, 1996.
47. Moberg, K., Starz, M. A., and Lees, J. A. E2F-4 switches from p130 to p107 and pRb in response to cell cycle entry. Mol. Cell. Biol., 16: 1436-1449, 1996.
48. Sardet, C., Vidai, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R. E2F-4 and E2F-5, two members of the E2F-family, are expressed in the early phase of the cell cycle. Proc. Natl. Acad. Sci. USA, 92: 2403-2407, 1995.
49. Coux, O., Tanaka, K., and Goldberg, A. L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem., 65: 801-847, 1996.
50. Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., and Schreiber, S. L. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science (Washington DC), 268: 726-731, 1995.
51. Rock, K. L, Gramm, C., Rothstein, L, Clark, K., Stein, R., Dick, L, Hwang, D., and Goldberg, A. L. Inhibitors of proteasome block the degradation of most cell proteins and generation of peptides presented on MHC class I molecules. Cell, 78: 761-771, 1994.
52. Morozov, A., Phelps, C. W., and Raychaudhuri, P. Activation of the c-fos gene by the HPV 16 oncoproteins depends upon the c-AMP response element at -60. J. Biol. Chem., 269: 18434-18440, 1994.
53. Dey, A., Atcha, I., and Bagchi, S. HPV16 E6 oncoprotein stimulates the transforming growth factor-β1 promoter in fibroblasts through a specific GC-rich sequence. Virology, 228: 190-199, 1997.
54. Moran, E. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev., 3: 63-70, 1993.
55. Hu, Q., Dyson, N., and Harlow, E. The regions of retinoblastoma protein needed for binding to the adenovirus E1A and SV40 T antigen are common sites for mutation. EMBO J., 9: 1147-1155, 1990.
56. Kaelin, W. G., Ewen, M. E., and Livingston, D. M. Definition of the minimal simian virus 40 large T antigen-and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol. Cell. Biol., 10: 3761-3769, 1990.
57. Bagchi, S., Raychaudhuri, P., and Nevins, J. R. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor, a novel mechanism for E1A transactivation. Cell, 62: 659-669, 1990.
58. Arroyo, M., and Raychaudhuri, P. Retinoblastoma-repression of the E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein. Nucleic Acids Res., 20: 5947-5954, 1992.
59. Hiebert, S. W., Chellapan, C., Horowitz, J., and Nevins, J. R. The interaction of Rb with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev., 6: 177-185, 1992.
60. Lee, E. Y-H. P., Chang, C-Y., Hu., N., Wang, Y-C. Lai, C. C., Herrup, K., Lee, W-H., and Bradley, A. Mice deficient for Rb are nonviable and show defects in neurogenesis and hematopoiesis. Nature (Lond.), 359: 288-294, 1992.
61. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., and Weinberg, R. A. Effects of an Rb mutation in the mouse. Nature (Lond.), 359: 295-300, 1992.
62. Cobrinik, D., Lee, M-H., Hannon, G., Mulligan, G., Bronson, R. T., Dyson, N., Harlow, E., Beach, D., Weinberg, R. A., and Jacks, T. Genes Dev., 10: 1633-1644, 1996.
63. Zerfass, K., Schulze, A., Spitkovsky, D., Friedman, V., Henglein, B., and Jansen-Durr, P. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol., 69: 6389-6399, 1995.
64. Berezutskaya, E., and Bagchi, S. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26S proteasome. J. Biol. Chem, in press, 1997.
65. Zhu, L, Heuvel, S., van den Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., and Harlow, E. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev., 7: 1111-1125, 1993.
66. Datta, P. K., Raychaudhuri, P., and Bagchi, S. Association of p107 with Sp1 : genetically separable regions of p107 are involved in regulation of E2F-and Sp1-dependent transcription. Mol. Cell. Biol., 15: 5444-5452, 1995.